Novartis Investigative Site

Kosice-Saca, Slovak Republic 040 15

0 studies enrolling now · 2 studies all time

What they study most

Chronic Plaque Type Psoriasis, Moderate to Severe Palmoplantar Psoriasis

Studies at this site

• Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed